Zimmer Biomet
1,018 hedge funds and large institutions have $30.1B invested in Zimmer Biomet in 2021 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 350 increasing their positions, 327 reducing their positions, and 89 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 350 | Existing positions reduced: 327
1% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 89
1% more capital invested
Capital invested by funds: $29.9B → $30.1B (+$259M)
0.32% more ownership
Funds ownership: 92.21% → 92.53% (+0.32%)
1% less funds holding
Funds holding: 1,030 → 1,018 (-12)
20% less call options, than puts
Call options by funds: $62.9M | Put options by funds: $78.8M
64% less funds holding in top 10
Funds holding in top 10: 14 → 5 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$295M |
| 2 |
Two Sigma Advisers
New York
|
+$197M |
| 3 |
Two Sigma Investments
New York
|
+$168M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$155M |
| 5 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$141M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$208M |
| 2 |
Millennium Management
New York
|
-$177M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$145M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$105M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$100M |
ZBH Hedge Fund Activity: Q2 2021 in Review
1,018 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q2 2021, worth a combined $30.1B — up 0.87% from $29.9B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new ZBH positions and 89 closed out — a net gain of 1 holder — while 350 added to existing stakes and 327 trimmed.
The largest buyer was Macquarie Group, adding an estimated $295M. The largest seller was Citadel Advisors, cutting an estimated $208M.
- 1,018 institutional investors held Zimmer Biomet (ZBH) as of Q2 2021, down from 1,030 in Q1 2021.
- Funds reported $30.1B of Zimmer Biomet stock for Q2 2021, up 0.87% quarter-over-quarter.
- 90 funds opened new Zimmer Biomet positions in Q2 2021 and 89 closed out, a net change of +1 holder.
- The largest Zimmer Biomet buyer in Q2 2021 was Macquarie Group, an estimated $295M added.
- The largest Zimmer Biomet seller in Q2 2021 was Citadel Advisors, an estimated $208M sold.
Based on aggregated 13F filings for Q2 2021.